EMA Grants Accelerated Assessment of Bristol-Myers Squibb's Empliciti

Monday, July 27, 2015

Source: European Pharmaceutical Review

Bristol-Myers Squibb and AbbVie have announced that the European Medicines Agency (EMA) validated for review their Marketing Authorisation Application (MAA) for Empliciti.

View All News »